Upper gastrointestinal bleeding on veno-arterial extracorporeal membrane oxygenation support - 08/01/26
, Yekcan Disli 1, Wulfran Bougouin 2, 7, Marie Renaudier 1, Ali Jendoubi 1, Jean-Claude Merle 1, Mathilde Delage 1, Lucile Picard 1, Faiza Sayagh 1, Chamsedine Cherait 1, Thierry Folliguet 3, 5, Christophe Quesnel 1, 5, Aymeric Becq 4, 5, Nicolas Mongardon 1, 5, 6, 7
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Abstract |
Introduction |
Patients on veno-arterial extracorporeal membrane oxygenation (V-A ECMO) support are at a high risk of hemorrhagic complications, including upper gastrointestinal bleeding (UGIB). The objective of this study was to evaluate the incidence and impact of this complication in V-A ECMO patients.
Materials and methods |
A retrospective single-center study (2013–2017) was conducted on V-A ECMO patients, excluding those who died within 24 h. All patients with suspected UGIB underwent esophagogastroduodenoscopy (EGD) and were analyzed and compared to the remainder of the cohort, from the initiation of ECMO until 5 days after explantation.
Results |
A total of 150 V-A ECMO cases (65 after cardiac surgery and 85 due to medical etiology) were included. 90% of the patients received prophylactic proton pump inhibitor therapy and enteral nutrition. Thirty-one patients underwent EGD for suspected UGIB, with 16 confirmed cases of UGIB. The incidence was 10.7%, with a median occurrence at 10 [7–17] days. There were no significant differences in clinical or biological characteristics on the day of EGD. However, patients with UGIB had significant increases in packed red blood cells and fresh frozen plasma needs, mechanical ventilation duration and V-A ECMO duration, as well as in length of intensive care unit and hospital stays. There was no significant difference in mortality. The only independent risk factor of UGIB was a history of peptic ulcer (OR = 7.32; 95% CI [1.07–50.01], p = 0.042).
Conclusion |
UGIB occurred in at least 1 out of 10 cases of V-A ECMO patients, with significant consequences on healthcare resources. Enteral nutrition and proton pump inhibitor prophylaxis did not appear to protect V-A ECMO patients. Further studies should assess their real benefits in these patients with high risk of hemorrhage.
Le texte complet de cet article est disponible en PDF.Keywords : Medical and Health Sciences, Clinical Sciences
Plan
Vol 14 - N° 1
Article 104- 2024 Retour au numéro
Article précédent
- Clinical phenotypes and outcomes associated with SARS-CoV-2 Omicron sublineage JN.1 in critically ill COVID-19 patients: a prospective, multicenter cohort study in France, November 2022 to January 2024
- Nicolas de Prost, Etienne Audureau, Antoine Guillon, Lynda Handala, Sébastien Préau, Aurélie Guigon, Fabrice Uhel, Quentin Le Hingrat, Flora Delamaire, Claire Grolhier, Fabienne Tamion, Alice Moisan, Cédric Darreau, Jean Thomin, Damien Contou, Amandine Henry, Thomas Daix, Sébastien Hantz, Clément Saccheri, Valérie Giordanengo, Tài Pham, Amal Chaghouri, Pierre Bay, Jean-Michel Pawlotsky, Slim Fourati, the SEVARVIR investigators, Keyvan Razazi, Armand Mekontso Dessap, Raphaël Bellaïche, Lucile Picard, Alexandre Soulier, Mélissa N’Debi, Sarah Seng, Christophe Rodriguez, Frédéric Pene, Anne-Sophie L’Honneur, Adrien Joseph, Elie Azoulay, Maud Salmona, Marie-Laure Chaix, Charles-Edouard Luyt, David Levy, Julien Mayaux, Stéphane Marot, Juliette Bernier, Maxime Gasperment, Tomas Urbina, Hafid Ait-Oufella, Eric Maury, Laurence Morand-Joubert, Djeneba Bocar Fofana, Jean-François Timsit, Diane Descamps, Guillaume Voiriot, Nina de Montmollin, Mathieu Turpin, Stéphane Gaudry, Ségolène Brichler, Tài Olivier Pham, Elyanne Gault, Sébastien Jochmans, Aurélia Pitsch, Guillaume Chevrel, Céline Clergue, Kubab Sabah, Laurence Courdavault Vagh Weinmann, Claudio Garcia-Sanchez, Ferhat Meziani, Louis-Marie Jandeaux, Samira Fafi-Kremer, Elodie Laugel, Sébastien Preau, Aurélie Guignon, Antoine Kimmoun, Evelyne Schvoerer, Cédric Hartard, Charles Damoisel, Nicolas Brechot, Helene Péré, François Beloncle, Francoise Lunel Fabiani, Rémi Coudroy, Arnaud W Thille, François Arrive, Sylvain le Pape, Laura Marchasson, Luc Deroche, Nicolas Leveque, Vincent Thibaut, Béatrice la Combe, Séverine Haouisee, Alexandre Boyer, Sonia Burrel, Gaetan Beduneau, Christophe Girault, Maximillien Grall, Dorothée Carpentier, Jean-Christophe Plantier, Emmanuel Canet, Audrey Rodallec, Berthe Marie Imbert, Sami Hraeich, Pierre-Edouard Fournier, Philippe Colson, Anaïs Dartevel, Sylvie Larrat, Guillaume Thiery, Sylvie Pillet, Kada Klouche, Edouard Tuaillon, Cécile Aubron, Adissa Tran, Sophie Vallet, Pierre-Emmanuel Charles, Alexis le Rougemont, Bertrand Souweine, Cecile Henquell, Audrey Mirand, Bruno Mourvillier, Laurent Andreoletti, Clément Lier, Damien du Cheyron, Nefert Candace Dossou, Astrid Vabret, Gaël Piton, Quentin Lepiller, Sylvie Roger
- Interpretation of results of PCR and B-D-glucan for the diagnosis of Pneumocystis Jirovecii Pneumonia in immunocompromised adults with acute respiratory failure
- Laure Calvet, Virginie Lemiale, Djamel Mokart, Schellongowski Peter, Pickkers Peter, Alexande Demoule, Sangeeta Mehta, Achille Kouatchet, Jordi Rello, Philippe Bauer, Ignacio Martin-Loeches, Amelie Seguin, Victoria Metaxa, Magali Bisbal, Elie Azoulay, Michael Darmon
Bienvenue sur EM-consulte, la référence des professionnels de santé.